Life sciences firm Malin looking to raise €31m in new share placing
Listed group, whose backers include Ireland Strategic Investment Fund, seeks new funds
Malin-backed Melinta gets Nasdaq listing after merger with Cempra
Melinta Therapeutics is Malin’s second-largest investment by capital committed
Malin invests $35m in Melinta in first post-IPO asset
Irish life sciences firm also commits further $10m in company
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices